SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001387308-16-000200
Filing Date
2016-05-26
Accepted
2016-05-26 15:41:29
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q A/1 form10qa1.htm 10-Q/A 47791
2 EX 31.1 ex311.htm EX-31.1 9832
3 EX 32.1 ex321.htm EX-32.1 5656
4 LOGO aximlogo3.jpg GRAPHIC 15392
  Complete submission text file 0001387308-16-000200.txt   1430413

Data Files

Seq Description Document Type Size
5 EX 101.INS axim-20160331.xml EX-101.INS 159907
6 EX 101.SCH axim-20160331.xsd EX-101.SCH 47766
7 EX 101.DEF axim-20160331_def.xml EX-101.DEF 22567
8 EX 101.CAL axim-20160331_cal.xml EX-101.CAL 9134
9 EX 101.LAB axim-20160331_lab.xml EX-101.LAB 196496
10 EX 101.PRE axim-20160331_pre.xml EX-101.PRE 121593
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54296 | Film No.: 161678003
SIC: 2834 Pharmaceutical Preparations